Acadia Pharmaceuticals | Capital Y Las Reservas



Equity Capital And Reserves Cambio Fecha
Acadia Pharmaceuticals USD 732.79M 155.61M 2024-12
ALKERMES USD 1.46B 172.88M 2024-12
Alnylam Pharmaceuticals USD 67.09M 34.73M 2024-12
Biogen USD 16.72B 357.1M 2024-12
BioMarin Pharmaceutical USD 5.66B 244.59M 2024-12
Bristol-Myers Squibb USD 16.34B 807M 2024-12
Corcept Therapeutics USD 679.59M 40.75M 2024-12
Cytokinetics USD -135372000 121.46M 2024-12
Eisai JPY 873.36B 53.3B 2024-12
Eli Lilly USD 14.19B 47.9M 2024-12
Incyte USD 3.45B 276.41M 2024-12
Intra Cellular Therapies USD 1.15B 3.63M 2024-12
J&J USD 71.49B 1.33B 2024-12
Moderna USD 10.9B 1.03B 2024-12
Neurocrine Biosciences USD 2.59B 129.2M 2024-12
Pfizer USD 88.2B 4.08B 2024-12
Prothena USD 486.93M 47.44M 2024-12
PTC Therapeutics USD -1098071000 43.72M 2024-12
Sarepta Therapeutics USD 1.53B 306.67M 2024-12
Ultragenyx Pharmaceutical USD 255.3M 91.53M 2024-12
Vertex Pharmaceuticals USD 16.41B 778.7M 2024-12



Acadia Pharmaceuticals Capital Y Las Reservas - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2025.